MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fgene.2026.1760869

Медицинская библиотека · Frontiers in genetics · 2026

Mitophagy-related molecular signatures in ulcerative colitis revealed by machine learning and molecular dynamics.

Han Yanru, Ren Weihua, Li Sujuan, Zhao Zhenxia, Lin Zhiqiang, Zhao Fucheng

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Ulcerative colitis (UC) is a lifelong, chronic inflammatory disorder, characterized by recurrent and diffuse inflammation of the rectal and colonic mucosa. Increasing evidence suggests that impaired mitophagy contributes to immune dysregulation and epithelial injury in UC. However, the mitophagy-related molecular landscape and its therapeutic potential remain largely unexplored.

METHODS

Mitophagy-related genes (MRGs) were intersected with differentially expressed genes to identify UC-associated MRGs. Functional enrichment, immune infiltration, and consensus clustering analyses were performed to characterize molecular subtypes. Three machine learning methods were employed to identify diagnostic models. Candidate therapeutic agents were identified by the CMap database.

RESULTS

A total of 35 UC-associated MRGs were identified, enriched in cell activation, fatty acid metabolism, and the PPAR signaling pathway, revealing strong immunometabolic coupling in UC. Consensus clustering stratified UC patients into two subtypes: a metabolism-dominant subtype (C1) and an inflammation-activated subtype (C2). Three hub genes-CD55, CPT1A, and SLC16A1-were screened and validated as robust diagnostic markers. Drug prediction and molecular docking revealed strong binding between galunisertib and CD55, which was further validated by molecular dynamics simulations. In vitro, galunisertib significantly suppressed inflammatory cytokine release in LPS-induced UC cell models.

DISCUSSION: This study delineated the mitophagy-related molecular signatures of UC and identified CD55, CPT1A, and SLC16A1 as key biomarkers linking mitochondrial dysfunction, metabolic reprogramming, and immune activation. Furthermore, galunisertib was proposed as a potential therapeutic agent, providing a theoretical basis for UC therapy.

Для цитирования: Han Yanru, Ren Weihua, Li Sujuan, Zhao Zhenxia, Lin Zhiqiang, Zhao Fucheng. Mitophagy-related molecular signatures in ulcerative colitis revealed by machine learning and molecular dynamics.. Frontiers in genetics. 2026. DOI: 10.3389/fgene.2026.1760869.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.